Literature DB >> 19054764

The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4.

Mohammad Al Sorkhy1, Ryan Craig, Brenna Market, Ryan Ard, Lisa A Porter.   

Abstract

Spy1A is a cyclin-like protein required for progression through the G(1)/S phase of the cell cycle. Elevated Spy1A protein levels have been implicated in tumorigenesis and are attributed to overriding the DNA damage response and enhancing cell proliferation. Understanding how Spy1A is produced and degraded is essential in resolving how it contributes to normal and abnormal growth processes. Herein, we demonstrate that Spy1A is degraded in a cell cycle-dependent manner during mitosis via the ubiquitin-proteasome system. We have resolved the E3 ligase and essential phosphorylation sites mediating Spy1A degradation. Furthermore, we have determined that non-degradable forms of Spy1A do not trigger cell cycle arrest but, rather, contribute to uncontrolled cell growth. Further investigation into the regulation of Spy1A may reveal novel strategies for understanding the etiology and progression of specific growth disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054764     DOI: 10.1074/jbc.M804847200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Evolution of the Cdk-activator Speedy/RINGO in vertebrates.

Authors:  Sangeeta Chauhan; Xinde Zheng; Yue Ying Tan; Boon-Hui Tay; Shuhui Lim; Byrappa Venkatesh; Philipp Kaldis
Journal:  Cell Mol Life Sci       Date:  2012-07-05       Impact factor: 9.261

2.  Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

Authors:  Denise A McGrath; Bre-Anne Fifield; Aimee H Marceau; Sarvind Tripathi; Lisa A Porter; Seth M Rubin
Journal:  EMBO J       Date:  2017-06-30       Impact factor: 11.598

Review 3.  NEDD4: The founding member of a family of ubiquitin-protein ligases.

Authors:  Natasha Anne Boase; Sharad Kumar
Journal:  Gene       Date:  2014-12-17       Impact factor: 3.688

Review 4.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

5.  Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.

Authors:  Mohammad Al Sorkhy; Bre-Anne Fifield; Dorothy Myers; Lisa A Porter
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 6.  Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions.

Authors:  B Yang; S Kumar
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

7.  The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.

Authors:  Mohammad Al Sorkhy; Rosa-Maria Ferraiuolo; Espanta Jalili; Agnes Malysa; Andreea R Fratiloiu; Bonnie F Sloane; Lisa A Porter
Journal:  BMC Cancer       Date:  2012-01-26       Impact factor: 4.430

8.  SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.

Authors:  Jia Liu; Lixin Wan; Pengda Liu; Hiroyuki Inuzuka; Jiankang Liu; Zhiwei Wang; Wenyi Wei
Journal:  Oncotarget       Date:  2014-02-28

9.  The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.

Authors:  Bre-Anne Fifield; Ingrid Qemo; Evie Kirou; Robert D Cardiff; Lisa Ann Porter
Journal:  Breast Cancer Res       Date:  2019-12-11       Impact factor: 6.466

Review 10.  The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.

Authors:  James A Conway; Grant Kinsman; Edgar R Kramer
Journal:  Genes (Basel)       Date:  2022-03-14       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.